本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Kiniksa Pharmaceuticals Ltd.

33.96
+0.39001.16%
成交量:6.41万
成交额:216.70万
市值:25.17亿
市盈率:514.26
高:34.09
开:33.57
低:33.42
收:33.57
52周最高:34.55
52周最低:17.82
股本:7,410.77万
流通股本:3,355.22万
量比:0.85
换手率:0.19%
股息:- -
股息率:- -
每股收益(TTM):0.0660
每股收益(LYR):-0.6047
净资产收益率:1.03%
总资产收益率:0.46%
市净率:5.08
市盈率(LYR):-56.16

数据加载中...

2025/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/29

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/29

重要事件披露

Form 8-K - Current report
2025/07/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/05

重要事件披露

Form 8-K - Current report
2025/06/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities